Redmile Group, LLC, 10% Owner at Verve Therapeutics, Inc. (VERV), bought 1,936,530 shares at $19.00 ($19.9M) on 2021-06-21, disclosed to the SEC on 2021-06-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 886,530 | $0 | 0.0% |
| 2 | $19.00 | 1,050,000 | $19.9M | 100.0% |
| Total | $10.30 avg | 1,936,530 | $19.9M | 100% |
| Filing → |
| FATE | BUY | 2023-12-28 | $332K | — | Filing → |
| IGMS | BUY | 2023-07-03 | $1.5M | — | Filing → |
| IGMS | SELL | 2023-07-03 | $1.5M | — | Filing → |